Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000004

Options or other derivatives

  • Chief Commercial Officer acquired 161,108 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Milanova Tsveta · Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-01-03 Grant or award : show line 1 in the form Stock option (right to buy) +135,682 135,682 D
2023-01-03 Grant or award : show line 2 in the form Restricted stock units +25,426 25,426 D
Loading xslF345X03/wf-form4_167295304325378.xml…